Operating profit before deduction of amortization: aptevotherapeutics.com (APVO)
The growth dynamics of Aptevo Therapeutics (APVO) rely on the development of immuno-oncology agents via the unique, patent-protected ADAPTIR platform. Monitoring of EBITDA_Co visualizes the returns from the core business, where 0.00 shows the value of this parameter. This confirms the company's status as an innovator in cancer therapy and enables it to retain a top-tier staff of chemists and medical executives.
Aptevo Therapeutics Inc. (APVO) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Aptevo Therapeutics|APVO - Long-Term Debt to Capital|Current Liabilities to Capital Aptevo Therapeutics, Inc.|APVO - Company Aggregate Debts|Debts to Book Capitalization Aptevo Therapeutics|APVO - Company Long-Term Debt|Current Liabilities Aptevo Therapeutics|Intermediate Liquidity Ratio aptevotherapeutics.com
- earnings and multiples data:
APVO - Net Profit|Expected Net Profit Aptevo Therapeutics|APVO - Price to Earnings Ratio|Future Price to Earnings Aptevo Therapeutics, Inc.|APVO - Price/Earnings to Growth Ratio|Company Value to EBITDA Aptevo Therapeutics|APVO - Operating profit before deduction of amortization|Earnings per share for the trailing year Aptevo Therapeutics|APVO - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months aptevotherapeutics.com|APVO - Earnings growth in current year|Expected earnings per share trend next year Aptevo Therapeutics
Summary company analytics:APVO (Aptevo Therapeutics)
Aptevo Therapeutics (APVO) cancer immunotherapy development is largely independent of market cycles, making the absolute EBITDA level a key indicator of the company's financial autonomy during periods of volatility. This metric measures net cash flow from core operations before interest, demonstrating the business's ability to generate cash to cover operating expenses without resorting to expensive debt capital.
Competitors of Aptevo Therapeutics (APVO)
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|VERA - Operating profit EBITDA|Dianthus Therapeutics (DNTH) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization PHVS (pharvaris.com)|Operating profit before deduction of amortization ABCL|TRML (Tourmaline Bio Inc) - Company profit before taxes, interest and amortization|Operating profit EBITDA PGEN|PHAR - Profit before interest, taxes and amortization|Nektar Therapeutics - Operating profit before deduction of amortization|upstreambio.com - Profit before payment of interest, taxes and amortization|ZBIO - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Immunome Inc|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KalVista Corp - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization SEPN|PVLA (pieris.com) - Company profit before taxes, interest and amortization|Operating profit EBITDA SVRA|RIGL (Rigel Pharma) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANAB (AnaptysBio Corp)|Astria Corp (ATXS) - Profit before interest, taxes and amortization|ENGN - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RAPT (RAPT Therapeutics Inc.)|JBIO: Operating profit EBITDA|Aclaris Therapeutics Inc. (ACRS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Kyverna|Tiziana Life Sciences, Ltd. - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CABA|VTYX - Profit before interest, taxes and amortization|Theratechnologies - Operating profit before deduction of amortization|Operating profit EBITDA Avalo Therapeutics, Inc. AVTX|ELDN: Operating profit before deduction of amortization|Agenus, Inc - Company profit before taxes, interest and amortization|CLYM: Operating profit EBITDA|ZURA - Operating income before deduction of amortization|ATYR (aTyr Pharma) - Operating profit EBITDA|Operating profit before deduction of amortization Adagene Corp (ADAG)|Profit before payment of interest, taxes and amortization ImageneBio Inc (IMA)|Operating income before deduction of amortization shattucklabs.com|Operating profit EBITDA EQ (Equillium)|Operating profit EBITDA Connect Biopharma Holdings CNTB|IMUX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ATRA|IFRX (inflarx.de) - Operating profit before deduction of amortization|XFOR (X4 Pharmaceuticals, Inc) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|Profit before interest, taxes and amortization Celularity Corp CELU|Profit before payment of interest, taxes and amortization INmune Bio (INMB)|BRNS: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA KZR (Kezar Life Sciences, Inc)|Income before deduction of interest, taxes and amortization SABS|Akari Therapeutics - Operating profit EBITDA|ENLV - Operating profit EBITDA|q32bio.com (QTTB) - Profit before payment of interest, taxes and amortization|GeoVax Labs - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Edesa|Operating profit before deduction of amortization iBio Corporation (IBIO)|Operating profit EBITDA CARM|Operating profit EBITDA xtlbio.com (XTLB)|Bolt Biotherapeutics, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HCWB|AIM ImmunoTech Inc. - Operating profit EBITDA|Operating income before deduction of amortization Aditxt ADTX|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization xortx.com|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before deduction of amortization Revelation Biosciences Inc (REVB)|Operating profit before deduction of amortization INDP (Indaptus)|Operating profit EBITDA BiondVax Pharmaceuticals (SCNI)|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD: Operating profit before amortization|Allakos Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization HOOKIPA Pharma Inc.|IGMS: Operating profit EBITDA|iTeos Pharma (ITOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|tcbiopharm.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit before deduction of amortization THRD (Third Harmonic Bio, Inc.)
